{"organizations": [], "uuid": "3ccb6cd560e2a28b3a49397f1c9d765a0746925d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180308.html", "section_title": "Archive News &amp; Video for Thursday, 08 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-interpace-diagnostics-announces-ad/brief-interpace-diagnostics-announces-additional-coverage-of-thyroid-tests-idUSFWN1QQ0UM", "country": "US", "domain_rank": 408, "title": "BRIEF-Interpace Diagnostics Announces Additional Coverage of Thyroid Tests", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.022, "site_type": "news", "published": "2018-03-08T21:16:00.000+02:00", "replies_count": 0, "uuid": "3ccb6cd560e2a28b3a49397f1c9d765a0746925d"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-interpace-diagnostics-announces-ad/brief-interpace-diagnostics-announces-additional-coverage-of-thyroid-tests-idUSFWN1QQ0UM", "ord_in_thread": 0, "title": "BRIEF-Interpace Diagnostics Announces Additional Coverage of Thyroid Tests", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-interpace diagnostics", "sentiment": "negative"}, {"name": "interpace diagnostics group inc", "sentiment": "negative"}, {"name": "thomson reuters trust principles", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "oss", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 8 (Reuters) - Interpace Diagnostics Group Inc :\n* INTERPACE DIAGNOSTICS - 4 ADDITIONAL BLUE CROSS BLUE SHIELD PLANS AGREED TO COVER BOTH OF INTERPACEâ€™S PROPRIETARY THYROID TESTS, THYGENX AND THYRAMIR Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-08T21:16:00.000+02:00", "crawled": "2018-03-09T14:41:59.008+02:00", "highlightTitle": ""}